Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1L - antineoplastic and immunomodulating agents----1件: 85 💬
2L 44----1件: 96 💬
3L acetyl carnitine----1件: 13 💬
4L-000124467----1件: 13 💬
5L-000124467-009J (succinat----1件: 46 💬
6L-000883191----1件: 46 💬
7L-001069957----1件: 46 💬
8L-123 ioflupane----1件: 6 💬
9L-3-(3,4-dihydroxyphenyl)alanine----1件: 6 💬
10L-883191----1件: 46 💬
11L-AA----1件: 240 💬
12L-alanine----1件: 299 💬
13L-arginin-hydrochlorid-einmolar fresenius1件: Arginine3件: Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬 		--1件: 65 💬
14L-arginine1件: L-arginine---5件: 2, 21, 46, 113, 299 💬
15L-carnitine1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--5件: 13, 46, 86, 96, 240 💬
16L-carnitine injection,1000MG once daily1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--1件: 2 💬
17L-citrulline----1件: 21 💬
18L-citrulline and metformin & L-citrulline1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
19L-citrulline malate----1件: 86 💬
20L-CSA----1件: 228 💬
21L-dopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
22L-dopa 140 MG1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
23L-dopa 35 MG1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
24L-dopa 70MG/carbidopa 7MG1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
25L-dopa/ modopar1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
26L-dopa/ddci1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
27L-dops1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
28L-fucose----1件: 65 💬
29L-glutamine1件: L-Glutamine1件: Glutamine 💬 --2件: 113, 299 💬
30L-histidine----1件: 13 💬
31L-leucine1件: Leucine1件: Leucine 💬 --1件: 284 💬
32L-lysine N acetylcysteinate----1件: 299 💬
33L-lysine N-acetylcysteinate----1件: 299 💬
34L-lysine- N-acetylcysteinate----1件: 299 💬
35L-lysine-N-acetyl-L-cysteinate----1件: 299 💬
36L-lysine-N-acetylcysteinate----1件: 299 💬
37L-lysyl-D-prolyl-L-threonine acetate1件: Acetate---1件: 97 💬
38L-lysyl-D-prolyl-lthreonine acetate, lyophilisate----1件: 97 💬
39L-methionine----1件: 84 💬
40L-serine----1件: 2 💬
41L-threo dops----1件: 17 💬
42L-tyrosine----2件: 6, 111 💬
43L0006cp03A----1件: 75 💬
44L01 - antineoplastic agents----1件: 85 💬
45L0122----1件: 279 💬
46L0133----1件: 50 💬
47L01aa03----1件: 28 💬
48L01BA----1件: 96 💬
49L01ba01----2件: 46, 107 💬
50L01bb04----1件: 13 💬
51L01fc01----1件: 63 💬
52L01X - other antineoplastic agents----1件: 85 💬
53L01X CO2----1件: 46 💬
54L01xc02----1件: 46 💬
55L01XE - protein kinase inhibitors----1件: 85 💬
56L01xe01----1件: 86 💬
57L01xe31 - nintedanib----1件: 85 💬
58L03 AB----1件: 13 💬
59L03 AB 08----1件: 13 💬
60L03 AB07----1件: 13 💬
61L03ab13----1件: 13 💬
62L04 AB04----1件: 46 💬
63L04aa04 - immunoglobulina antitimocitaria (DI coniglio) immunoglobulina DI coniglio antitimociti umani thymoglobuline1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬1件: 13 💬
64L04aa10----2件: 278, 280 💬
65L04aa11----1件: 46 💬
66L04aa18----1件: 158 💬
67L04aa24----2件: 46, 271 💬
68L04aa25----1件: 62 💬
69L04aa26----1件: 49 💬
70L04aa31----1件: 13 💬
71L04ab0----2件: 46, 271 💬
72L04ab01----2件: 46, 271 💬
73L04ab04----5件: 46, 96, 107, 160, 271 💬
74L04ab05----2件: 46, 271 💬
75L04ac06----2件: 44, 45 💬
76L04ac07----2件: 41, 46 💬
77L04ax01----1件: 96 💬
78L04ax03----1件: 46 💬
79L606 (liposomal treprostinil) inhalation solution 51UG----1件: 86 💬
80L606 inhalation system----1件: 86 💬
81L608 inhalation solution----1件: 86 💬
82L608 liposomal inhalation solution----1件: 86 💬
83LA294----1件: 49 💬
84LAB work----1件: 46 💬
85Laba/lama----1件: 299 💬
86Laboratory assessment: calcium----3件: 3, 15, 256 💬
87Laboratory assessment: creatine kinase----3件: 3, 15, 256 💬
88Laboratory assessment: magnesium----3件: 3, 15, 256 💬
89Laboratory assessment: phosphate----3件: 3, 15, 256 💬
90Laboratory assessment: vitamin D level----3件: 3, 15, 256 💬
91Laboratory assessments----1件: 85 💬
92Laboratory biomarker analysis----22件: 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
93Laboratory experiments before and after mepolizumab treatment----2件: 44, 45 💬
94Laboratory testing----3件: 84, 97, 271 💬
95Laboratory tests----3件: 19, 113, 256 💬
96Lacosamide1件: Lacosamide1件: Lacosamide 💬 2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
97Lacryvisc1件: Carbomer---1件: 53 💬
98Lactated ringer----1件: 296 💬
99Lactated ringers----2件: 96, 97 💬
100Lacteol forte capsules1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 49 💬
101Lactic acid producing organisms1件: Lactic acid2件: Lactic acid ,
Sodium lactate 💬 		--1件: 299 💬
102Lactizole nebulization----1件: 299 💬
103Lactobacillus----1件: 51 💬
104Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 6 💬
105Lactobacillus casei1件: Lactobacillus casei1件: Lactobacillus casei 💬 --3件: 6, 97, 296 💬
106Lactobacillus casei DG1件: Lactobacillus casei1件: Lactobacillus casei 💬 --1件: 97 💬
107Lactobacillus GG----1件: 97 💬
108Lactobacillus plantarum1件: Lactobacillus plantarum---2件: 6, 97 💬
109Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
110Lactobacillus reuteri1件: Lactobacillus reuteri---2件: 97, 299 💬
111Lactobacillus rhamnosus1件: Lacticaseibacillus rhamnosus---1件: 299 💬
112Lactobacillus rhamnosus GG1件: Lacticaseibacillus rhamnosus---1件: 299 💬
113Lactobacillus rhamnosus GG atcc 531031件: Lacticaseibacillus rhamnosus---1件: 97 💬
114Lactobacillus salivarius UCC1181件: Lactobacillus salivarius---2件: 96, 97 💬
115Lactobacilus acidophilus & bifidobacterium animalis/lactis----1件: 97 💬
116Lactose1件: Lactose2件: Anhydrous lactose ,
Lactose 💬 		--5件: 2, 6, 21, 228, 310 💬
117Lactose IN water1件: Lactose2件: Anhydrous lactose ,
Lactose 💬 		--1件: 97 💬
118Lactose monohydrate1件: Lactose2件: Anhydrous lactose ,
Lactose 💬 		--1件: 13 💬
119Lactose sachet1件: Lactose2件: Anhydrous lactose ,
Lactose 💬 		--1件: 97 💬
120Lactulose1件: Lactulose1件: Lactulose 💬 --3件: 6, 13, 97 💬
121Lactulose/rhamnose solution1件: Lactulose1件: Lactulose 💬 --1件: 96 💬
122Ladarixin1件: Ladarixin---1件: 162 💬
123Lademirsen1件: Lademirsen---1件: 218 💬
124Ladicell----1件: 65 💬
125LAM-001----1件: 228 💬
126LAM-002A----1件: 2 💬
127Lamazym1件: Velmanase alfa1件: Velmanase alfa 💬 1件: MAN2B1 💬 2件: Lysosome, Other glycan degradation 💬1件: 19 💬
128Lamictal1件: Lamotrigine1件: Lamotrigine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 144 💬
129Lamivudine1件: Lamivudine1件: Lamivudine 💬 --7件: 2, 26, 42, 46, 135, 265, 325 💬
130Lamivudine/zidovudine1件: Lamivudine1件: Lamivudine 💬 --1件: 265 💬
131Lamotrigin actavis----2件: 113, 114 💬
132Lamotrigin beta----2件: 34, 195 💬
133Lamotrigin ”nordic prime 100 MG----1件: 114 💬
134Lamotrigin ”nordic prime 25 MG----1件: 114 💬
135Lamotrigin ”nordic prime 50 MG----1件: 114 💬
136Lamotrigine1件: Lamotrigine1件: Lamotrigine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 13, 34, 113, 114, 144 💬
137Lamotrigine - generic product1件: Lamotrigine1件: Lamotrigine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 38 💬
138Lamotrigine 25MG oral tablet, extended release1件: Lamotrigine1件: Lamotrigine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114 💬
139Lamotrigine dispers1件: Lamotrigine1件: Lamotrigine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 34 💬
140Lamotrigine extended release tablets1件: Lamotrigine1件: Lamotrigine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
141Lanadelumab1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
142Lanadelumab 150 MG1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
143Lanadelumab 300 MG1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
144Land exercises----1件: 46 💬
145Landmark-based intrathecal administration OF nusinersen----1件: 3 💬
146Language intervention----1件: 206 💬
147Lanifibranor1件: Lanifibranor---1件: 51 💬
148Lanraplenib1件: Lanraplenib1件: Lanraplenib 💬 --2件: 53, 222 💬
149Lanreotida autogel 120 MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
150Lanreotide1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 73, 77 💬
151Lanreotide (autogel formulation), duration OF treatment 24-56 weeks, depending ON dose interval1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
152Lanreotide (autogel formulation), duration OF treatment 46-48 weeks1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
153Lanreotide 60MG solution FOR injection1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
154Lanreotide acetate1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 67, 77, 85, 298 💬
155Lanreotide acetato1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
156Lanreotide ATG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
157Lanreotide ATG 120MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
158Lanreotide autogel1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
159Lanreotide autogel 120 MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
160Lanreotide autogel 120MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
161Lanreotide autogel and octreotide LAR1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
162Lanreotide PRF1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
163Lanreotide-autogel 120 MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
164Lansolprazole----1件: 166 💬
165Lansoprazole1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬4件: 71, 85, 166, 299 💬
166Lansoprazole 30MG1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 166 💬
167Lansoprazole, amoxicillin, clarithromycin1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 222 💬
168Lansoprazole, clarithromycin, amoxycillin1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 63 💬
169Lantarel----1件: 46 💬
170Lantus 100 units/ML solution FOR injection IN A cartridge----1件: 299 💬
171Lantus® 100 units/ML solution FOR injection IN A vial. lantus® 100 units/ML solution FOR injection IN A cartridge. lantus® 100 units/ML solution FOR injection IN A PRE-filled PEN----1件: 299 💬
172LAP TAP bupivacaine/epinephrine----2件: 96, 97 💬
173Lapaquistat acetate and current lipid-lowering treatment1件: Lapaquistat---1件: 79 💬
174Lapatinib1件: Lapatinib2件: Lapatinib ditosylate ,
Lapatinib 💬 		2件: EGFR,
ERBB2 💬 		48件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬3件: 34, 74, 75 💬
175Lapine T-lymphocyte immune globulin1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬4件: 62, 65, 284, 286 💬
176Laquinimod1件: Laquinimod1件: Laquinimod sodium 💬 --4件: 8, 13, 49, 96 💬
177Laquinimod 0.31件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
178Laquinimod 0.61件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
179Laquinimod 1.21件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
180Laquinimod capsulas 0.6 MG1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
181Laquinimod capsules 0.3 MG1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
182Laquinimod capsules 0.5 MG1件: Laquinimod1件: Laquinimod sodium 💬 --2件: 8, 96 💬
183Laquinimod capsules 0.6 MG1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
184Laquinimod Cápsulas 0.5 MG1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 96 💬
185Laquinimod tablets 0.3 MG1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
186Large dose OF prednisolone plus intra-lesional OF triamcinolone acetonide followed THE systemic combination OF mycophenolate mofetil (MMF), dapsone and LOW dose prednisolone IN treatment OF MMP----1件: 162 💬
187Large neutral amino acid therapy----1件: 240 💬
188Large protein molecule----1件: 46 💬
189Lariam1件: Mefloquine2件: Mefloquine hydrochloride ,
Mefloquine 💬 		--1件: 25 💬
190Laronidase1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬2件: 19, 256 💬
191Laronidase ERT1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
192Laronidase therapy and A stem cell transplant1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
193Laser, exercise, and methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
194Late biologic therapy----1件: 96 💬
195Latozinemab1件: Latozinemab1件: Latozinemab 💬 1件: SORT1 💬 3件: Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬1件: 127 💬
196Latrepirdine1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬 		6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
197LAU-7B----1件: 299 💬
198Lavender OIL1件: Lavender oil1件: Lavender oil 💬 --1件: 13 💬
199LAX-1011件: LAX-101---1件: 8 💬
200LB-P6----1件: 46 💬
201LB-P81件: LB-P8---1件: 46 💬
202LB-P8 HIGH-dose1件: LB-P8---1件: 94 💬
203LB-P8 LOW-dose1件: LB-P8---1件: 94 💬
204Lbal----1件: 46 💬
205LBEC0101----1件: 46 💬
206LBS-008, BPN-14967----1件: 301 💬
207LBT-3627----1件: 6 💬
208LC51-0255----1件: 97 💬
209LCAR-AIO T cells----3件: 11, 13, 49 💬
210LCI699----1件: 75 💬
211LCI699, 1 MG----1件: 75 💬
212LCI699, 10 MG----1件: 75 💬
213LCI699, 20 MG----1件: 75 💬
214LCI699, 5 MG----1件: 75 💬
215Lcig----1件: 6 💬
216LCZ696----1件: 58 💬
217LCZ696 100 MG----1件: 58 💬
218LCZ696 200 MG----1件: 58 💬
219LCZ696 50 MG----1件: 58 💬
220LD / BE----1件: 6 💬
221LD+ddci----1件: 6 💬
222LD-aminopterin----1件: 46 💬
223LD-ddci----1件: 6 💬
224LD/CD----1件: 6 💬
225LD/CD SC solution----1件: 6 💬
226LDP-02----2件: 96, 97 💬
227LE051----1件: 113 💬
228Learning----1件: 13 💬
229Lebrikizumab1件: Lebrikizumab1件: Lebrikizumab 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 85 💬
230Lederspan----1件: 107 💬
231Ledertrexate----1件: 46 💬
232Ledertrexato----1件: 46 💬
233Ledertrexato 2,5 MG compriméS----1件: 46 💬
234Ledipasvir/sofosbuvir1件: Ledipasvir1件: Ledipasvir 💬 --1件: 19 💬
235Lefamulin1件: Lefamulin2件: Lefamulin ,
Lefamulin acetate 💬 		--1件: 299 💬
236Leflunomide1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬13件: 11, 40, 46, 49, 53, 54, 66, 107, 162, 224, 270, 271, 300 💬
237Leflunomide 20 MG+prednisone 0.5MG/KG/D1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 66 💬
238Leflunomide 20MG TAB1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
239Leflunomide 20MG/D1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 53 💬
240Leflunomide mylan1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 53 💬
241Leflunomide-sulfasalazine-hydroxychloroquine1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
242Leflunomidum1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
243Lemborexant 5 MG1件: Lemborexant1件: Lemborexant 💬 2件: HCRTR1,
HCRTR2 💬 		2件: Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 127 💬
244Lemtrada1件: Alemtuzumab1件: Alemtuzumab 💬 --2件: 13, 65 💬
245Lemtrada 12 MG konzentrat ZUR herstellung einer infusionslösung1件: Alemtuzumab1件: Alemtuzumab 💬 --1件: 13 💬
246Lenabasum1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299 💬
247Lenabasum 20 MG1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 51, 299 💬
248Lenabasum 20 MG powder IN capsule1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
249Lenabasum 5 MG1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 51, 299 💬
250Lenabasum 5 MG powder IN capsule1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
251Lenabasum 5MG powder IN capsule1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
252Lenadogene nolparvovec1件: Lenadogene nolparvovec---1件: 302 💬
253Lenalidomide1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
254Lenalidomide 25MG1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
255Lenalidomide and dexamethasone1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
256Lenalidomide+dexamethasone1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
257Lenalidomide, dexamethasone1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
258Lenalidomide, dexamethasone and cyclophosphamide1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
259Lengthening adalimumab dosing interval----1件: 96 💬
260Leniolisib1件: Leniolisib2件: Leniolisib ,
Leniolisib phosphate 💬 		3件: PIK3CA_B_D,
PIK3CA_B_D,
PIK3CA_B_D 💬 		103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬2件: 53, 65 💬
261Leniolisib phosphate1件: Leniolisib2件: Leniolisib ,
Leniolisib phosphate 💬 		3件: PIK3CA_B_D,
PIK3CA_B_D,
PIK3CA_B_D 💬 		103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 65 💬
262Lenogastrim----1件: 28 💬
263Lenograstim1件: Lenograstim1件: Lenograstim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬8件: 2, 13, 16, 18, 19, 57, 65, 97 💬
264Lenrispodun----1件: 6 💬
265Lenti-D1件: Elivaldogene tavalentivec---1件: 20 💬
266Lenti-D drug product1件: Elivaldogene tavalentivec---1件: 20 💬
267Lentiviral G1xcgd gene therapy----1件: 65 💬
268Lentiviral gene transfer----1件: 65 💬
269Lentiviral vector containing ABCA4 gene----1件: 301 💬
270Lentiviral vector containing MYO7A gene----2件: 90, 303 💬
271Lentiviral vector containing THE ABCA4 gene----1件: 301 💬
272Lentiviral vector containing THE human MY07A gene----2件: 90, 303 💬
273Lentiviral vector trans-skip gene modified autologous mesoangioblasts----1件: 113 💬
274Lentiviral vector transduced CD34+ cells----1件: 65 💬
275Lentivirus alpha-GAL A transduced stem cells----1件: 19 💬
276Lenzumestrocel1件: Lenzumestrocel---1件: 2 💬
277Leptin1件: Leptin---2件: 6, 265 💬
278Lepunafusp alfa1件: Lepunafusp alfa---1件: 19 💬
279Leqvio 284 MG solution FOR injection IN PRE-filled syringe1件: Inclisiran2件: Inclisiran ,
Inclisiran sodium 💬 		1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
280Leramistat----1件: 85 💬
281Leriglitazone1件: Leriglitazone1件: Leriglitazone 💬 1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 20 💬
282Lerodalcibep1件: Lerodalcibep1件: Lerodalcibep 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
283Letairis1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
284Letairis 10 MG1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
285Letairis 5 MG1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
286Letermovir1件: Letermovir1件: Letermovir 💬 --1件: 85 💬
287Letrozole1件: Letrozole1件: Letrozole 💬 1件: CYP19A 💬 2件: Ovarian steroidogenesis, Steroid hormone biosynthesis 💬2件: 81, 89 💬
288Leucine1件: Leucine1件: Leucine 💬 --4件: 6, 283, 284, 299 💬
289Leucovorin1件: Leucovorin3件: Leucovorin calcium ,
Folinic acid ,
Folinic acid calcium salt pentahydrate 💬 		--2件: 19, 46 💬
290Leukapheresis----5件: 49, 51, 96, 284, 285 💬
291Leukapheresis- collection OF stem cells----1件: 96 💬
292Leukine1件: Sargramostim1件: Sargramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 28, 229 💬
293Leukopheresis----1件: 51 💬
294Leuplin DPS 11.25MG----1件: 76 💬
295Leuprolide1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬4件: 1, 2, 3, 76 💬
296Leuprolide acetate 11.25 MG/ML1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
297Leuprolide acetate 3 month depot1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
298Leuprolide acetate 45 MG1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
299Leuprolide acetate depot1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
300Leuprolide mesylate, subcutaneous injection OF 42 MG leuprolide1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
301Leuprorelin1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 67, 76 💬
302Leuprorelin acetate1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 1, 76 💬
303Leuprorelin acetate 3.75MG injection1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
304Leuprorelin acetate depot 3M1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
305Levact----1件: 61 💬
306Levamisole1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--2件: 61, 222 💬
307Levamisole hydrochloride1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 60 💬
308Levamisole+cyclosporin A+glucocorticoids2件: Cyclosporine,
Levamisole		3件: Cyclosporine ,
Levamisole hydrochloride ,
Levamisole 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 62 💬
309Levaquin----1件: 84 💬
310Levemir 100 U/ML solution FOR injection IN A cartridge, levemir 100 U/ML solution FOR injection IN A PRE-filled PEN----1件: 299 💬
311Levemir flexpen----1件: 299 💬
312Levemir penfill----1件: 299 💬
313Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2 💬 1件: ECM-receptor interaction 💬7件: 2, 4, 6, 13, 34, 149, 307 💬
314Levitra1件: Vardenafil2件: Vardenafil ,
Vardenafil hydrochloride 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 13, 86 💬
315Levobupivacaine1件: Levobupivacaine2件: Levobupivacaine hydrochloride ,
Levobupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 46 💬
316Levocarnil----1件: 13 💬
317Levocarnitine1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--3件: 3, 53, 97 💬
318Levocarnitine propyl hydrochloride1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--1件: 97 💬
319Levocetirizina dicloridrato1件: Levocetirizine2件: Levocetirizine ,
Levocetirizine dihydrochloride 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 61 💬
320Levocitirizina----1件: 61 💬
321Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 6, 17, 140, 201 💬
322Levodopa (drug), intraduodenal administration1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
323Levodopa (L-dopa) + standard care1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
324Levodopa / benserazid1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
325Levodopa / benserazide 200 + 50 MG1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
326Levodopa / carbidopa solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
327Levodopa 100 MG / benserazide 25 MG1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
328Levodopa 100 MG A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
329Levodopa 125 MG A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
330Levodopa 150 MG A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
331Levodopa 75 MG A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
332Levodopa acute challenge1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
333Levodopa and carbidopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
334Levodopa and decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
335Levodopa and domperidone1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
336Levodopa benserazide madopar1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
337Levodopa benserazide teva italia1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
338Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
339Levodopa cyclops1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
340Levodopa dispersible1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
341Levodopa formulation1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
342Levodopa infusion1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
343Levodopa INN1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
344Levodopa MR1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
345Levodopa or acupuncture1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
346Levodopa powder FOR inhalation1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
347Levodopa tablet1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
348Levodopa test1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 17 💬
349Levodopa, carbidopa, entacapone1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
350Levodopa, carbidopa, ODM-1041件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
351Levodopa, decarboxylase inhibitor and comt inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
352Levodopa-4'-monophosphate2件: Foslevodopa,
Levodopa		2件: Levodopa ,
Foslevodopa 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
353Levodopa-carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 90 💬
354Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
355Levodopa-carbidopa immediate release1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
356Levodopa-carbidopa immediate release (LC-IR) tablets1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
357Levodopa-carbidopa intestinal GEL1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
358Levodopa-carbidopa multilayer extended release tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
359Levodopa-carbidopa-entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
360Levodopa/benserazide1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
361Levodopa/benserazide 100/25 MG1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
362Levodopa/benzeraside1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
363Levodopa/benzerazide1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
364Levodopa/carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 164 💬
365Levodopa/carbidopa 100/251件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
366Levodopa/carbidopa oral formulation A1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
367Levodopa/carbidopa oral formulation B1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
368Levodopa/carbidopa oral formulation C1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
369Levodopa/carbidopa solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
370Levodopa/carbidopa solution FOR SC administration1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
371Levodopa/carbidopa/entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
372Levodopa/ddci1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
373Levodopa/dopa decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
374Levofloxacin1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--4件: 46, 53, 84, 299 💬
375Levofloxacin hemihydrate1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--1件: 299 💬
376Levofloxacin kabi1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--1件: 299 💬
377Levofolene 4 MG 30 CPR1件: Levoleucovorin3件: Levoleucovorin calcium ,
Sodium levofolinate ,
Calcium levofolinate hydrate 💬 		--1件: 13 💬
378Levoketoconazole1件: Levoketoconazole1件: Levoketoconazole 💬 3件: CYP11A,
CYP11B1,
CYP17A 💬 		6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75 💬
379Levoketozonazole----1件: 75 💬
380Levonorgestrel1件: Levonorgestrel1件: Levonorgestrel 💬 1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
381Levosimendan1件: Levosimendan1件: Levosimendan 💬 2件: PDE3A,
PDE3B 💬 		10件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
382Levothyroxine1件: Levothyroxine3件: Levothyroxine sodium ,
Levothyroxine ,
Levothyroxine sodium 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬3件: 49, 78, 80 💬
383Levotonine----1件: 97 💬
384Levovanox----2件: 94, 97 💬
385Levulan (5-aminolevulinic acid) photodynamic therapy - dose level 1----1件: 34 💬
386Levulan (5-aminolevulinic acid) photodynamic therapy - dose level 2----1件: 34 💬
387Levulan (5-aminolevulinic acid) photodynamic therapy - dose level 3----1件: 34 💬
388LFB-igsc----1件: 65 💬
389LFB-R603----1件: 13 💬
390LFB-R603, TGTX1101----1件: 13 💬
391LFG316----1件: 62 💬
392LGD-4665----1件: 63 💬
393Liatermin1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
394LIB003----1件: 79 💬
395Liberation therapy----1件: 13 💬
396Licorice1件: Licorice1件: Glycyrrhiza 💬 --3件: 46, 53, 224 💬
397Lidocaine1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬10件: 6, 13, 22, 46, 86, 107, 168, 226, 231, 256 💬
398Lidocaine 1% injectable solution1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬2件: 34, 168 💬
399Lidocaine 2% without vessel constrictor1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 51 💬
400Lidocaine hydrochloride1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
401Lidocaine hydrochloride, injectable1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
402Lidocaine IV1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 298 💬
403Lifestyle----1件: 58 💬
404Light transmission aggregometry----2件: 86, 88 💬
405Ligustrazine1件: Ligustrazine---2件: 46, 296 💬
406Limaprost1件: Limaprost1件: Limaprost 💬 1件: PTGER1 💬 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬1件: 70 💬
407Limphostat-B----1件: 53 💬
408Linaclotide1件: Linaclotide2件: Linaclotide acetate ,
Linaclotide 💬 		1件: GUCY2C 💬 2件: Hormone signaling, Purine metabolism 💬2件: 6, 97 💬
409Linerixibat1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
410Linerixibat (GSK2330672) 40 MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
411Linerixibat (GSK2330672) 45 MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
412Linerixibat (GSK2330672) 45MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
413Linez----1件: 299 💬
414Linezolid1件: Linezolid1件: Linezolid 💬 --1件: 299 💬
415Lingzhi and SEN miao SAN----1件: 46 💬
416Linoleic acid1件: Linoleic acid---1件: 13 💬
417Linoleic acid supplementation1件: Linoleic acid---1件: 299 💬
418Linoleic acid/oleic acid1件: Linoleic acid---1件: 13 💬
419Linperlisib1件: Linperlisib---1件: 61 💬
420Linsitinib1件: Linsitinib1件: Linsitinib 💬 1件: IGF1R 💬 28件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 232 💬
421Linvoseltamab1件: Linvoseltamab1件: Linvoseltamab 💬 1件: TNFRSF17 💬 2件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production 💬1件: 28 💬
422Liofen XL----1件: 13 💬
423Lioresal*50CPR 10MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
424Liothyronine1件: Liothyronine2件: Liothyronine sodium ,
Liothyronine 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 13 💬
425Liothyronine I 1312件: Liothyronine,
Liothyronine I-131		3件: Liothyronine sodium ,
Liothyronine I 131 ,
Liothyronine 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬2件: 210, 212 💬
426Liothyronine sodium1件: Liothyronine2件: Liothyronine sodium ,
Liothyronine 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 13 💬
427Lipasa----1件: 299 💬
428Lipase----2件: 298, 299 💬
429Lipase clec----1件: 299 💬
430Lipase LIP2 from yarrowia lipolytica----1件: 299 💬
431Lipid injectable emulsion with fish OIL----1件: 294 💬
432Lipiodol® ultra fluid with surgical glues----1件: 280 💬
433Lipitor1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬3件: 51, 96, 299 💬
434Lipoic acid1件: Lipoic acid1件: Thioctic acid 💬 --3件: 13, 14, 20 💬
435Lipoic acid (LA) with fish OIL and LA without fish OIL1件: Lipoic acid1件: Thioctic acid 💬 --1件: 13 💬
436Lipoic acid and omega-3 fatty acids1件: Lipoic acid1件: Thioctic acid 💬 --1件: 13 💬
437Lipoic acid group1件: Lipoic acid1件: Thioctic acid 💬 --1件: 2 💬
438Lipopolysaccharide----1件: 6 💬
439Liposic----1件: 53 💬
440Liposomal aerosol cyclosporine----1件: 228 💬
441Liposomal amikacin1件: Amikacin2件: Amikacin sulfate ,
Amikacin 💬 		--1件: 299 💬
442Liposomal amikacin FOR inhalation----1件: 299 💬
443Liposomal bupivacaine1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 51, 70, 96 💬
444Liposomal curcumin----1件: 97 💬
445Liposomal cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
446Liposomal cyclosporine A 10 MG----1件: 228 💬
447Liposomal cyclosporine A 5 MG----1件: 228 💬
448Liposomal doxorubicin1件: Doxorubicin2件: Doxorubicin hydrochloride ,
Doxorubicin 💬 		--1件: 331 💬
449Liposomal T4n5 lotion----1件: 159 💬
450Liposome encapsulated BONT-A----1件: 226 💬
451Liposomed polyphenols resveratrol and curcumin----1件: 2 💬
452Liposomes----1件: 226 💬
453Lipoxygenase inhibitor----1件: 160 💬
454Liprotamasa----1件: 299 💬
455Liprotamase----2件: 298, 299 💬
456Liprotamase powder FOR oral solution----1件: 299 💬
457LIQ861 100 µG----1件: 86 💬
458LIQ861 106 µG----1件: 86 💬
459LIQ861 25 µG----1件: 86 💬
460LIQ861 26.5 µG----1件: 86 💬
461LIQ861 50 µG----1件: 86 💬
462LIQ861 53 µG----1件: 86 💬
463LIQ861 75 µG----1件: 86 💬
464LIQ861 79.5 µG----1件: 86 💬
465LIQ861 inhaled treprostinil----1件: 86 💬
466Liqourice----1件: 75 💬
467Liquid bubble sampling----1件: 162 💬
468Liquigen MCT OIL----1件: 6 💬
469Liquorice1件: Licorice1件: Glycyrrhiza 💬 --1件: 83 💬
470Liraglutide1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 6, 13, 75, 77, 193 💬
471Lirentelimab1件: Lirentelimab1件: Lirentelimab 💬 --1件: 98 💬
472Liris 400 MG----1件: 226 💬
473Liris LOW dose and liris high dose----1件: 226 💬
474Liris® 400 MG----1件: 226 💬
475Lisdexamfetamine sulfate1件: Lisdexamfetamine2件: Lisdexamfetamine dimesylate ,
Lisdexamfetamine 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
476Lisinopril1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬5件: 19, 46, 66, 67, 113 💬
477Lisinopril pills1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 49 💬
478Lisinopril, losartan, and atorvastatin1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 222 💬
479Lisparin----1件: 6 💬
480Listed FOR each disorder below, UP TO three drugs PER disorder (TOO many characters TO list IN this field----1件: 13 💬
481Lisuride1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 86 💬
482Lisuride hydrogenmaleate1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
483Lisuride transdermal system1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
484Lisuride TTS1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
485Lithium----5件: 2, 5, 6, 7, 8 💬
486Lithium apogepha2件: Lithium carbonate,
Lithium citrate		2件: Lithium carbonate ,
Lithium citrate 💬 		--1件: 2 💬
487Lithium aspartate----1件: 6 💬
488Lithium carbonate2件: Lithium carbonate,
Lithium citrate		2件: Lithium carbonate ,
Lithium citrate 💬 		--5件: 2, 13, 17, 18, 127 💬
489Lithium carbonate 400 MG1件: Lithium carbonate1件: Lithium carbonate 💬 --1件: 2 💬
490Lithium carbonate capsule1件: Lithium carbonate1件: Lithium carbonate 💬 --1件: 310 💬
491Lithium citrate2件: Lithium carbonate,
Lithium citrate		2件: Lithium carbonate ,
Lithium citrate 💬 		--1件: 2 💬
492Lithiumcarbonaat 400 PCH tabletten----1件: 2 💬
493Litifilimab1件: Litifilimab1件: Litifilimab 💬 --1件: 49 💬
494Litio carbonato----2件: 2, 17 💬
495LIV-gamma SN INJ.----1件: 63 💬
496LIV001----1件: 97 💬
497Live combined bacillus subtilis and enterococcus faecium enteric-coated capsules combined with bortezomib+dexamethasone/bortezomib+dexamethasone+daratumumab/single daratumumab3件: Bortezomib,
Daratumumab,
Dexamethasone		5件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬 		3件: CD38,
NR3C1,
PSMB5 💬 		15件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬
498Live combined bifidobacterium,lactobacillus and enterococcus capsules----1件: 6 💬
499Live hookworm larvae----1件: 13 💬
500Live necator americanus larvae----1件: 13 💬
501Live SK08 powder----1件: 97 💬
502Liver biopsy----3件: 171, 231, 240 💬
503Liver evaluation----1件: 240 💬
504Liver questionnaire----1件: 231 💬
505Liver transplantation----1件: 94 💬
506Livoletide1件: Livoletide---1件: 193 💬
507Lixacol----1件: 97 💬
508Lixisenatide1件: Lixisenatide1件: Lixisenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
509Lixivaptan1件: Lixivaptan1件: Lixivaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
510LJN452----1件: 93 💬
511LJN452, 0,01 MG----1件: 93 💬
512LJN452, 0,03 MG----1件: 93 💬
513LJN452, 0,1 MG----1件: 93 💬
514LJP 394----1件: 49 💬
515LJP394----1件: 49 💬
516LMI070----2件: 3, 8 💬
517LMT503----2件: 96, 97 💬
518Lmtm1件: Hydromethylthionine mesylate1件: Hydromethylthionine mesylate 💬 1件: MAPT 💬 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 127 💬
519Lmtm/TRX02371件: Hydromethylthionine mesylate1件: Hydromethylthionine mesylate 💬 1件: MAPT 💬 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 127 💬
520Lmwh/rivaroxaban----1件: 75 💬
521LMX 4 topical cream----1件: 256 💬
522LMY-920----1件: 49 💬
523LNK01001----2件: 46, 271 💬
524LNK01001 dose A----1件: 46 💬
525LNK01001 dose B----1件: 46 💬
526LNP023----5件: 61, 62, 66, 109, 222 💬
527LNP023 hydrochlori----1件: 66 💬
528LNP023 hydrochloride salt----2件: 62, 222 💬
529LNP1955----1件: 46 💬
530LO-ovral oral contraceptive pills----1件: 60 💬
531LO2A EYE drops----1件: 53 💬
532LO4ab02----1件: 96 💬
533LO4ab04----1件: 46 💬
534Lobivon*28CPR 5MG----1件: 167 💬
535Lobster device1件: Lobster---1件: 70 💬
536Local injection OF normal saline----1件: 96 💬
537Local trade name, 2MG----1件: 6 💬
538Local trade name, 4MG----1件: 6 💬
539Local trade name, 8MG----1件: 6 💬
540Lodosyn----1件: 13 💬
541Lodotra----1件: 41 💬
542Lojuxta 10 MG hard capsules1件: Lomitapide2件: Lomitapide ,
Lomitapide mesylate 💬 		1件: MTTP 💬 1件: Fat digestion and absorption 💬1件: 79 💬
543Lojuxta 20 MG hard capsules1件: Lomitapide2件: Lomitapide ,
Lomitapide mesylate 💬 		1件: MTTP 💬 1件: Fat digestion and absorption 💬1件: 79 💬
544Lojuxta 5 MG hard capsules1件: Lomitapide2件: Lomitapide ,
Lomitapide mesylate 💬 		1件: MTTP 💬 1件: Fat digestion and absorption 💬1件: 79 💬
545Lokomat training----1件: 13 💬
546Lomecel-B medicinal signaling cells----1件: 211 💬
547Lomerizine1件: Lomerizine---1件: 124 💬
548Lomitapide1件: Lomitapide2件: Lomitapide ,
Lomitapide mesylate 💬 		1件: MTTP 💬 1件: Fat digestion and absorption 💬1件: 79 💬
549Lomitapide 2MG hard capsules1件: Lomitapide2件: Lomitapide ,
Lomitapide mesylate 💬 		1件: MTTP 💬 1件: Fat digestion and absorption 💬1件: 79 💬
550Lonafarnib1件: Lonafarnib1件: Lonafarnib 💬 2件: FNTA,
FNTB 💬 		1件: Terpenoid backbone biosynthesis 💬2件: 113, 333 💬
551Lonafarnib, zoledronic acid, and pravastatin1件: Lonafarnib1件: Lonafarnib 💬 2件: FNTA,
FNTB 💬 		1件: Terpenoid backbone biosynthesis 💬1件: 333 💬
552Long term follow UP IN ALL patients WHO received SAR422459 IN previous study TDU13583----1件: 301 💬
553Long term follow-UP----1件: 169 💬
554Long term oxygen therapy----1件: 88 💬
555LONG-acting somatostatin----1件: 67 💬
556LONG-chain N-3 pufa----1件: 46 💬
557LONG-circulating liposomal prednisolone----1件: 46 💬
558Longeveron mesenchymal stem cells1件: Allogenic bone marrow-derived mesenchymal stem cells---1件: 211 💬
559Lonodelestat----1件: 299 💬
560Lonoten----1件: 179 💬
561Lopace----1件: 19 💬
562Loperamide1件: Loperamide2件: Loperamide hydrochloride ,
Loperamide 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 13, 97 💬
563Loperamide hydrochloride1件: Loperamide2件: Loperamide hydrochloride ,
Loperamide 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
564Lopinavir1件: Lopinavir1件: Lopinavir 💬 --1件: 265 💬
565Lopinavir/ritonavir1件: Lopinavir1件: Lopinavir 💬 --1件: 265 💬
566Lopinavir/ritonavir + nevirapine1件: Lopinavir1件: Lopinavir 💬 --1件: 265 💬
567Lopinavir/ritonavir + zidovudine + lamivudine1件: Lopinavir1件: Lopinavir 💬 --1件: 265 💬
568Loratadina stada 10 MG1件: Loratadine1件: Loratadine 💬 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 89 💬
569Loratadine1件: Loratadine1件: Loratadine 💬 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 13, 19, 46, 89, 98 💬
570Lorazepam1件: Lorazepam1件: Lorazepam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 36, 231 💬
571Lorcaserin1件: Lorcaserin2件: Lorcaserin hydrochloride ,
Lorcaserin hydrochloride hemihydrate 💬 		1件: HTR2 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 140 💬
572Lorenzo'S OIL----1件: 20 💬
573Lortaan*28CPR RIV DIV 50MG----1件: 167 💬
574Losartan1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬15件: 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
575Losartan and nebivolol2件: Losartan,
Nebivolol		4件: Losartan potassium ,
Nebivolol ,
Nebivolol hydrochloride ,
Losartan 💬 		2件: ADRB1,
AGTR1 💬 		24件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
576Losartan and other angiotensin receptor blockers1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 19 💬
577Losartan bluefish 50 MG1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
578Losartan hexal1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 36 💬
579Losartan potasico1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 179 💬
580Losartan potassium1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 36, 98, 167, 179, 215 💬
581Losartan tablets & qingremoshen granule1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
582Losec1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬3件: 46, 225, 294 💬
583Losec capsules 20 MG1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 46 💬
584Losmapimod1件: Losmapimod1件: Losmapimod 💬 4件: P38,
P38,
P38,
P38 💬 		62件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬2件: 113, 222 💬
585LOU064----2件: 13, 53 💬
586LOU064c1----1件: 13 💬
587Lovastatin1件: Lovastatin1件: Lovastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬11件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
588Lovastatin 60 MG1件: Lovastatin1件: Lovastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 34 💬
589Lovastatin, then minocycline/lovastatin2件: Lovastatin,
Minocycline		3件: Lovastatin ,
Minocycline hydrochloride ,
Minocycline 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 206 💬
590Lovoldyl*30CPR RIV 5MG----1件: 97 💬
591LOW antigen content diet----1件: 66 💬
592LOW blood pressure control----1件: 67 💬
593LOW calorie protein substitute----1件: 240 💬
594LOW carbohydrate ketogenic diet----1件: 256 💬
595LOW copper diet----1件: 171 💬
596LOW dietary sodium----1件: 49 💬
597LOW dose----1件: 97 💬
598LOW dose (1 MCG) acth stimulation test----1件: 193 💬
599LOW dose affitope® PD03A + adjuvant----1件: 6 💬
600LOW dose ARM receiving neutral OIL and 400 IU/G OF vitamin D every second DAY----1件: 13 💬
601LOW dose AT-GTX-502----1件: 19 💬
602LOW dose bibf 1120 twice daily----1件: 85 💬
603LOW dose BIBF1120 once daily----1件: 85 💬
604LOW dose budesonide----1件: 97 💬
605LOW dose budesonide rectal foam----1件: 97 💬
606LOW dose budesonide tablet----1件: 98 💬
607LOW dose cannabis1件: Medical Cannabis1件: Cannabis 💬 --1件: 13 💬
608LOW dose GR1603 IN phase ?B----1件: 49 💬
609LOW dose levodopa----1件: 6 💬
610LOW dose LX2006----1件: 18 💬
611LOW dose MT-1303----1件: 97 💬
612LOW dose myobloc----1件: 13 💬
613LOW dose naltrexone----2件: 96, 97 💬
614LOW dose OF biil 284 BS tablets----1件: 46 💬
615LOW dose ORTD-1----1件: 46 💬
616LOW dose prednisolone----1件: 84 💬
617LOW dose TSO----1件: 96 💬
618LOW dose vehicle control----1件: 46 💬
619LOW DOSE-VIS649----1件: 66 💬
620LOW energy diode laser----1件: 35 💬
621LOW fiber diet----1件: 96 💬
622LOW fodmap----1件: 97 💬
623LOW fodmap diet----1件: 97 💬
624LOW glycemic index meal----1件: 299 💬
625LOW immunogenic interferon-BETA-1A----1件: 13 💬
626LOW molecular weight heparin calcium injection----1件: 224 💬
627LOW N-6 pufa diet----1件: 96 💬
628LOW protein and high fiber diet----1件: 97 💬
629LOW residue diet intervention----1件: 21 💬
630LOW serine diet----1件: 96 💬
631LOW-dose CICR-NAM----1件: 97 💬
632LOW-dose IL-2----1件: 56 💬
633LOW-dose IL-2 administration----1件: 96 💬
634LOW-dose interleukin-2----1件: 53 💬
635LOW-dose naltrexone----1件: 226 💬
636LOW-dose REGN4461----1件: 265 💬
637LOW-FAT control diet----1件: 124 💬
638LOW-frequency-only stimulation----1件: 6 💬
639LOW-intensity exercise therapy----1件: 298 💬
640LOW-volume C1-esterase inhibitor----1件: 65 💬
641Lower limb strength----1件: 6 💬
642Loxoprofen1件: Loxoprofen1件: Loxoprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
643Loxoprofen sodium hydrogel patch1件: Loxoprofen1件: Loxoprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
644Loxoprofen sodium tablet1件: Loxoprofen1件: Loxoprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
645LP-08 20MG----1件: 226 💬
646LP-08 80MG----1件: 226 💬
647LP-168 tablet----1件: 13 💬
648LP352----2件: 140, 144 💬
649LP352, bexicaserin----2件: 140, 144 💬
650LPA1----1件: 85 💬
651LPM3770164 sustained release tablet----1件: 8 💬
652LPM3770164 sustained release tablet simulant----1件: 8 💬
653LPX-TI641----2件: 13, 46 💬
654LT-02----1件: 97 💬
655LTI-031件: LTI-03---1件: 85 💬
656LTP----1件: 86 💬
657LTP001----2件: 85, 86 💬
658LTS 0.25MG----1件: 46 💬
659LTS 0.5MG----1件: 46 💬
660LTS 1.0MG----1件: 46 💬
661LU 00-800----1件: 6 💬
662LU 70274----1件: 299 💬
663LU AA24493----1件: 18 💬
664LU AF28996----1件: 6 💬
665LU AF82422----2件: 6, 17 💬
666LU AG06466----1件: 13 💬
667LU AG13909----2件: 75, 81 💬
668Lubiprostone1件: Lubiprostone1件: Lubiprostone 💬 1件: CLCN2 💬 1件: Mineral absorption 💬5件: 6, 13, 97, 290, 299 💬
669Lucen----1件: 113 💬
670Lucentis1件: Ranibizumab1件: Ranibizumab 💬 1件: VEGFA 💬 23件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 166 💬
671Lucerastat1件: Lucerastat1件: Lucerastat 💬 1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
672Lucinactant first1件: Lucinactant1件: Lucinactant 💬 --1件: 299 💬
673Lucrin----1件: 67 💬
674Lulizumab pegol1件: Lulizumab pegol---1件: 49 💬
675LUM----1件: 299 💬
676LUM/IVA----1件: 299 💬
677LUM/IVA fixed-dose combination----1件: 299 💬
678LUM001----5件: 93, 94, 296, 297, 338 💬
679Lumacaftor1件: Lumacaftor1件: Lumacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
680Lumacaftor / ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
681Lumacaftor plus ivacaftor1件: Lumacaftor1件: Lumacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
682Lumacaftor plus ivacaftor combination2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
683Lumacaftor, ivacaftor drug combination1件: Lumacaftor1件: Lumacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
684Lumacaftor-ivacaftor1件: Lumacaftor1件: Lumacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
685Lumacaftor-ivacaftor treatment1件: Lumacaftor1件: Lumacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
686Lumacaftor/ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
687Lumacaftor/ivacaftor 100MG/125MG tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
688Lumacaftor/ivacaftor 200MG/125MG2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
689Lumacaftor/ivacaftor 200MG/125MG tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
690Lumacaftor/ivacaftor 200MG/83MG tablet2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
691Lumasiran1件: Lumasiran2件: Lumasiran ,
Lumasiran sodium 💬 		1件: HAO 💬 2件: Glyoxylate and dicarboxylate metabolism, Peroxisome 💬1件: 234 💬
692Lumason® contrast agent----1件: 21 💬
693Lumbar epidural injection----1件: 70 💬
694Lumbar interbody fusion----1件: 70 💬
695Lumbar interbody fusion with autograft----1件: 70 💬
696Lumbar interbody fusion with neofuse----1件: 70 💬
697Lumbar interlaminar epidural steroid injection----1件: 70 💬
698Lumbar punction----1件: 8 💬
699Lumbar puncture----6件: 6, 13, 19, 96, 97, 127 💬
700Lumentin 44----1件: 96 💬
701Lumipulse (fujirebio) abeta42, ttau and ptau----5件: 5, 6, 7, 17, 127 💬
702Lumiracoxib1件: Lumiracoxib1件: Lumiracoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
703Lunasin regimen1件: Lunasine---1件: 2 💬
704Lung clearance index----1件: 299 💬
705Lung spheroid stem cells 100 million----1件: 85 💬
706Lung spheroid stem cells 200 million----1件: 85 💬
707Lung stem cells----1件: 85 💬
708LUO-FU-shan plaster----1件: 46 💬
709Lupus impact tracker questionnaire----1件: 49 💬
710Lupuzor----1件: 49 💬
711Luspatercept1件: Luspatercept1件: Luspatercept 💬 1件: ACVR2B 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬3件: 60, 61, 282 💬
712Luspatercept combine with deferasirox1件: Luspatercept1件: Luspatercept 💬 1件: ACVR2B 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 60 💬
713Lusutrombopag1件: Lusutrombopag1件: Lusutrombopag 💬 1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
714Lusutrombopag oral tablet1件: Lusutrombopag1件: Lusutrombopag 💬 1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
715Lusvertikimab1件: Lusvertikimab1件: Lusvertikimab 💬 1件: IL7R 💬 7件: Cytokine-cytokine receptor interaction, FoxO signaling pathway, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency 💬1件: 97 💬
716Lutein1件: Lutein---2件: 13, 90 💬
717Lutein (10 or 30 MG/DAY) capsules1件: Lutein---1件: 90 💬
718Lutein plus zeaxanthin1件: Lutein---1件: 164 💬
719Luteinizing hormone-releasing factor1件: Luteinizing hormone---1件: 254 💬
720Lutenyl----1件: 13 💬
721Lutikizumab1件: Lutikizumab1件: Lutikizumab 💬 2件: IL1A,
IL1B 💬 		44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬3件: 46, 96, 97 💬
722LW402----1件: 46 💬
723LX1606----1件: 97 💬
724LX3305----1件: 46 💬
725LX3305 250 MG capsule----1件: 161 💬
726LX3305 dihydrate----1件: 46 💬
727LX3305 high dose----1件: 46 💬
728LX3305 LOW dose----1件: 46 💬
729LX3305 MID dose----1件: 46 💬
730LY-M001----1件: 19 💬
731LY-M001 injection----1件: 19 💬
732LY03003----1件: 6 💬
733LY03009 F1----1件: 6 💬
734LY03009 F2----1件: 6 💬
735LY03009 F3----1件: 6 💬
736LY03009 F4----1件: 6 💬
737LY03017----1件: 6 💬
738LY2127399----3件: 13, 46, 49 💬
739LY2189102----1件: 46 💬
740LY2439821----3件: 46, 107, 271 💬
741LY248686----1件: 13 💬
742LY300164----1件: 6 💬
743LY3009104----10件: 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
744LY3074828----2件: 96, 97 💬
745LY3090106----1件: 53 💬
746LY3090106 - IV----1件: 46 💬
747LY3090106 - SQ----1件: 46 💬
748LY3154207----1件: 6 💬
749LY3337641----1件: 46 💬
750LY3337641 20 MG----1件: 46 💬
751LY3337641 5 MG----1件: 46 💬
752LY3361237----2件: 49, 53 💬
753LY3462817----1件: 46 💬
754LY3471851----2件: 49, 97 💬
755LY3541860----2件: 13, 46 💬
756LY3871801----1件: 46 💬
757LY38849611件: LY3884961---2件: 6, 19 💬
758LY3884963----1件: 127 💬
759LY3962681----1件: 6 💬
760LY4006896----1件: 6 💬
761LY450190----1件: 86 💬
762LYC-30937----1件: 97 💬
763LYC-30937-EC----1件: 97 💬
764Lycium barbarum----1件: 90 💬
765LYM-X-sorb powder----1件: 299 💬
766Lymphocyte gene therapy----1件: 19 💬
767Lymphocyte immune globulin----1件: 96 💬
768Lymphodepleting chemotherapy----2件: 49, 51 💬
769Lymphoseek1件: Tilmanocept---1件: 46 💬
770Lymphostat-B----1件: 49 💬
771Lymphostat-B (LSB), monoclonal ANTI-blys, LSB----1件: 49 💬
772Lymphostat-B TM----1件: 49 💬
773Lyophilized concentrate OF human coagulation VON willebrand factor and factor viii----1件: 288 💬
774Lyrica1件: Pregabalin1件: Pregabalin 💬 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬 		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 298 💬
775LYS-GM101----1件: 19 💬
776LYS-SAF3021件: Olenasufligene relduparvovec---1件: 19 💬
777LYS006----1件: 97 💬
778Lysine1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 228 💬
779Lysine-D-proline-threonine1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 97 💬
780Lysodase1件: PEG-Glucocerebrosidase---1件: 19 💬
781LYT-100----1件: 85 💬
782Lzrse-COL7a1 engineered autologous epidermal sheets----1件: 36 💬